In Ohio, the Cleveland Clinic joined the Circulating Cell-free Genome Atlas, a national clinical trial that is looking for 7,000 cancer patients and 3,000 healthy patients in the U.S. Their goal is to analyze DNA and RNA in the blood and build a database that will help with detecting cancer early on when it is easier to cure. Researchers believe that using genome sequencing from blood samples could possibly replace x-rays for early cancer detection. Funded by a company in California, GRAIL, Inc., the project will be looking for molecule patterns in the blood for specific types of cancers.
Latest article
Bruce the dog reviews cultivated meat
In Scotland, Philip Lymbery, a journalist writing for The Scotsman has turned to his beloved pup Bruce to review Chick Bites dog treats, the...
Breaking nugget news: Japanese scientists create lab-growth chicken with circulatory system
In Tokyo, researchers have created the world’s largest, and most advanced, lab-growth chicken nugget.
Featuring “veins” that deliver nutrients and oxygen, the new nugget...
Be green on the green with biodegradable golf balls
In Vancouver, a company is selling golf balls that biodegrade in two weeks and are made from compressed corn starch, calcium carbonate, glycerin, and...